FDA inspection
Lilly France S.A.S.: FDA inspection ending Feb 19, 2019
FDA inspection 1081382 · Voluntary Action Indicated (VAI) · Fegersheim
Key facts
| Inspection ID | 1081382 |
|---|---|
| Firm | Lilly France S.A.S. |
| FEI number | 3002807475 |
| Address | 2 Rue Du Colonel Lilly |
| City | Fegersheim |
| Fiscal year | 2019 |
| Inspection end date | Feb 19, 2019 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | New Drug Evaluation |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data